Because MTHFR converts folate into L-methylfolate, the active form, if an individual has a genetic polymorphism that decreases or inhibits this conversion, it is reasonable to assume that this population may be more at risk for MDD and perhaps treatment-resistant MDD. This evidence concerns the gene MTHFR and major depressive disorder.